Molina Healthcare

Valuation Analysis

About the Company

Molina Healthcare en bref

Molina Healthcare (MOH) is currently trading at 169,60 € with a market capitalization of 8,9 Md €. The trailing P/E ratio stands at 1222.62x, with a forward P/E of 20.08x. The 52-week range spans from 104,96 € to 212,32 €; the current price is 20.1% below the yearly high. Year-over-year revenue growth stands at -5.7%.

💰 Dividende

Molina Healthcare currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

17 analystes évaluent Molina Healthcare (MOH) au consensus : Conserver. L'objectif de cours moyen est de 181,31 €, soit un potentiel de +6.9% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 127,45 € à 230,62 €.

Molina Healthcare : la thèse d'investissement en détail

Molina Healthcare (MOH) operates in the Healthcare — specifically Healthcare Plans — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario baissier

Revenue is contracting at -5.7% year-over-year — until that trend reverses, valuation is exposed to further downgrades. Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders. A trailing P/E above 50 combined with revenue growth below 20% is a dangerous combination — the market is paying a steep growth multiple for what is, by the data, only moderately fast expansion.

Signal Smart Money

On the institutional side, Molina Healthcare appears in the disclosed holdings of Burry. Smart-money managers track positioning, fundamentals and competitive dynamics with research budgets few retail investors can match — when several converge on the same name, it is rarely random. That doesn't mean blind copying makes sense, but it does raise the bar for the bear case.

À surveiller

• The forward P/E of 20.08x is meaningfully below the trailing 1222.62x — analysts expect earnings to step up; the next earnings release is the test.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price shows short-term weakness (below 50d MA) but is still in a longer-term uptrend (above 200d MA).

Profil de risque

The data points to relatively defensive market behavior, elevated short interest (7.47%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Molina Healthcare?

Compare top-rated brokers — low fees, trusted providers, fully regulated.